Cargando…

Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives

BRAF mutations constitute an important poor prognostic factor in metastatic colorectal cancer (mCRC) and the development of treatments in this context is of great necessity to prolong patient survival. Although the association between BRAF mutations and microsatellite instability (MSI) has been know...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Hiroyuki, Sunakawa, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027060/
https://www.ncbi.nlm.nih.gov/pubmed/33842313
http://dx.doi.org/10.3389/fonc.2021.602194